A BILL 
To amend the Public Health Service Act to authorize grants 
to certain public health laboratories to assist such labora-
tories in meeting the cost of acquiring high-throughput 
diagnostic equipment, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Diagnostic Testing for 
4
Public Health Labs Act of 2020’’. 
5
18:57 Jun 17, 2020
H7025
2 
•HR 7025 IH
SEC. 2. GRANTS FOR PUBLIC HEALTH LABORATORIES TO 
1
ACQUIRE 
HIGH-THROUGHPUT 
DIAGNOSTIC 
2
EQUIPMENT. 
3
Section 2821 of the Public Health Service Act (42 
4
U.S.C. 300hh–31) is amended— 
5
(1) by redesignating subsection (b) as sub-
6
section (c); 
7
(2) in subsection (c), as so redesignated— 
8
(A) by redesignating paragraphs (1), (2), 
9
and (3) as subparagraphs (A), (B), and (C), re-
10
spectively, and moving the margin of each such 
11
redesignated subparagraph 2 ems to the right; 
12
and 
13
(B) by striking ‘‘There are authorized to 
14
be appropriated to carry out this section’’ and 
15
inserting the following: 
16
‘‘(1) IN GENERAL.—There are authorized to be 
17
appropriated to carry out subsection (a)’’; 
18
(3) by inserting after subsection (a) the fol-
19
lowing new subsection: 
20
‘‘(b) GRANTS FOR PUBLIC HEALTH LABORATORIES 
21
TO ACQUIRE HIGH-THROUGHPUT DIAGNOSTIC EQUIP-
22
MENT.— 
23
‘‘(1) GRANTS.—The Secretary, acting through 
24
the Director of the Centers for Disease Control and 
25
Prevention, shall award grants to eligible entities to 
26
18:57 Jun 17, 2020
H7025
3 
•HR 7025 IH
assist such entities in purchasing high-throughput 
1
diagnostic equipment and related supplies. 
2
‘‘(2) ELIGIBILITY.—To be eligible for a grant 
3
under paragraph (1), an entity shall— 
4
‘‘(A) be— 
5
‘‘(i) a State, local, or Tribal public 
6
health laboratory; 
7
‘‘(ii) a laboratory within a public 
8
health laboratory network coordinated or 
9
managed by the Centers for Disease Con-
10
trol and Prevention; 
11
‘‘(iii) a laboratory not described in 
12
clause (i) or (ii) that the Secretary deter-
13
mines (at the Secretary’s discretion) pro-
14
vides population-based testing for the pre-
15
vention and control of infectious, commu-
16
nicable, genetic, or chronic diseases; or 
17
‘‘(iv) a consortium of 2 or more enti-
18
ties described in any of clauses (i) through 
19
(iii); and 
20
‘‘(B) submit to the Secretary an applica-
21
tion at such time, in such manner, and con-
22
taining such information as the Secretary may 
23
reasonably require. 
24
18:57 Jun 17, 2020
H7025
4 
•HR 7025 IH
‘‘(3) 
USE
OF
FUNDS.—Amounts 
received 
1
through a grant under this subsection shall be used 
2
to purchase high-throughput diagnostic equipment 
3
and such materials as are necessary to administer, 
4
store, and process applicable tests, including diag-
5
nostic and serological tests. 
6
‘‘(4) AMOUNT OF GRANT.—The amount of a 
7
grant under paragraph (1) may not exceed 
8
$2,000,000, except in the case of eligible entity de-
9
scribed in paragraph (2)(A)(iv). 
10
‘‘(5) HIGH-THROUGHPUT
DIAGNOSTIC
EQUIP-
11
MENT DEFINED.—In this subsection, the term ‘high- 
12
throughput diagnostic equipment’ means legally- 
13
marketed equipment and supplies capable of per-
14
forming multichannel analysis for use in clinical lab-
15
oratory diagnostic testing.’’; and 
16
(4) by adding at the end of subsection (c), as 
17
redesignated, the following new paragraph: 
18
‘‘(2) AUTHORIZATION OF APPROPRIATIONS.— 
19
‘‘(A) IN
GENERAL.—For the purpose of 
20
carrying out subsection (b), there is authorized 
21
to be appropriated $250,000,000 for fiscal year 
22
2020, to remain available until expended. 
23
‘‘(B) ADMINISTRATIVE EXPENSES.—Of the 
24
amount made available to carry out subsection 
25
18:57 Jun 17, 2020
H7025
5 
•HR 7025 IH
(b) for any fiscal year, the Secretary may not 
1
use more than 5 percent of such amount for the 
2
expenses of administering subsection (b).’’. 
3
Æ 
18:57 Jun 17, 2020
H7025
